The risk of voting no is Pfizer walk, but we are $4m better off and have amazing global publicity and validation from a world leading pharma. No cap raise anytime soon. It really doesn’t sound that bad TBH. The upside to this risk is that Pfizer up their bid to around 28c.
The risk of voting yes is massive opportunity cost. I would be confident of getting FDA for Dx and this is solid 24 carat gold encrusted with diamonds. What ever you say about COVID, it has pushed Telehealth into orbit and clinically validated respiratory diagnostic credentials throughout the USA and other countries that follow them is both the goose and the golden eggs. Don’t forget FDA on SleepCheck as well. The world needs Dx, it’s just they don’t realise it yet.
